Abstract:Background: Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness although there it has been linked to premature death, hypertension, ischaemic heart disease, stroke and road traffic accidents. Objectives: The main treatment for sleep apnoea is with continuous positive airways pressure (CPAP) treatment, which consists of a flow generator and mask. These are used at night to prevent apnoea, hypoxia and sleep disturbance. The objective was to assess the effects of CPAP in the treatment of obstructive sleep apnoea in adults. Search strategy: We searched the Cochrane Airways Group RCT register (MEDLINE 1966 to 2000, Embase 1974 to 2000, Cinahl 1982 to 2000) and the reference lists of articles. We consulted experts in the field. Selection criteria: Randomised trials comparing nocturnal CPAP with placebo or other treatments in adults with obstructive sleep apnoea and an apnoea/hypopnoea index greater than five per hour. Data collection and analysis: Trial quality was assessed and two reviewers extracted data independently. Study authors were contacted for missing information. Main results: Twelve trials involving 475 people were included. Most studies had methodological shortcomings. Most trials were of crossover design. Compared with placebo, CPAP showed significant improvements in objective and subjective sleepiness and several quality of life and depression measures. Patients preferred CPAP to placebo (odds ratio 0.4, 95% confidence interval 0.2 to 0.8). There was no significant effect on daytime blood pressure. Compared with oral appliances, CPAP significantly improved the apnoea/hypopnoea index (weighted mean difference -7.3, 95% confidence interval -10.0 to -4.7) and minimum oxygen saturation during sleep. Patients strongly preferred the oral appliance to CPAP (odds ratio 9.5, 95% confidence interval 4.3 to 21.1). Reviewer's conclusions: CPAP is more effective than placebo in improving sleepiness and quality of life measures for people with obstructive sleep apnoea. It is more effective than oral appliances in improving respiratory disturbances. Although patients prefer CPAP to placebo, they preference oral appliances to CPAP.

Continuous positive airway pressure for treating high blood pressure of patients with obstructive sleep apnea-hypopnea syndrome：a meta-analysis

Meta-analysis: the efficacy of continuous positive airway pressure therapy on blood pressure in obstructive sleep apnea hypopnea syndrom patients

Beneficial Response of Blood Pressure to Short-Term Continuous Positive Airway Pressure in Chinese Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Effects of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: a Systematic Review and Meta-Analysis of Six Randomized Controlled Trials

Comprehensive curative effect of CPAP combined with conventional antihypertensive drugs on OSAHS patients with hypertension based on Meta-analysis

Effect of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: An Updated Meta-analysis

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].

Analysis of the improvement of quality of life in patients with obstructive sleep apnea hypopnea syndromes associated hypertension with continuous positive airway pressure

A randomized controlled trial on ambulatory blood pressure lowering effect of CPAP in patients with obstructive sleep apnea and nocturnal hypertension

Effect of continuous positive airway pressure therapy on blood pressure variability of obstructive sleep apnea hypopnea syndrome

Continuous positive airway pressure adherence and blood pressure lowering in patients with obstructive sleep apnoea syndrome and nocturnal hypertension

Effect of Continuous Positive Airway Pressure on Cardiometabolic Risk Factors in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

Does Continuous Positive Airway Pressure Therapy Benefit Patients with Coronary Artery Disease and Obstructive Sleep Apnea? A Systematic Review and Meta‐analysis

Does Continuous Positive Airway Pressure Therapy Benefit Patients With Coronary Artery Disease And Obstructive Sleep Apnea? A Systematic Review And Meta-Analysis

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

E ectiveness of Oral Appliance versus Continuous Positive Airway Pressure in Treating Patients with Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome: A Meta-Analysis

Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis

Effect on Quality of Life of Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea Syndrome: A Meta-analysis

Continuous positive airways pressure for obstructive sleep apnoea

The effect of nCPAP short-term treatment on blood pressure and hs-CRP in refractory hypertension patients complicated with OSAHS

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients